Arkolith/Insider Trading/XFOR/Form 4

Wyzga Michael S

DirectorX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4 · filed Aug 22, 2023
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2023Buy(P)25K$1.20$30K77K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-23-030224) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML